3597-44-2

Basic information

• Product Name: 17-alpha-hydroxy-3,11-dioxoandrost-4-ene-17-beta-carboxylic acid
• Synonyms: 17-hydroxy-3,11-dioxoandrost-4-ene-17-carboxylic acid
• CAS NO: 3597-44-2
• Molecular Formula: C₂₀H₂₆O₅
• Molecular Weight: 346.4174
• Mol File: 3597-44-2.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 567.7°C at 760 mmHg
• Flash Point: 311.2°C
• Density: 1.31g/cm³
• Vapor Pressure: 2.99E-15mmHg at 25°C
• Refractive Index: 1.593
• CAS DataBase Reference: 17-alpha-hydroxy-3,11-dioxoandrost-4-ene-17-beta-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 17-alpha-hydroxy-3,11-dioxoandrost-4-ene-17-beta-carboxylic acid(3597-44-2)
• EPA Substance Registry System: 17-alpha-hydroxy-3,11-dioxoandrost-4-ene-17-beta-carboxylic acid(3597-44-2)

Safety Data

• Hazardous Substances Data: 3597-44-2(Hazardous Substances Data)

Usage

Type

Synthetic androgen and anabolic steroid

Parent compound

Testosterone

Potency

Potent androgenic hormone

Medical use

Promotes muscle growth and masculine characteristics in men with low testosterone levels

Agricultural use

Promotes growth and improves feed efficiency in livestock

Legal status

Controlled substance in many countries

Potential for abuse

High due to its anabolic and androgenic effects

Negative side effects

Liver toxicity and cardiovascular risks

Application

Medical treatment and agricultural use

Chemical structure

Modified testosterone molecule with a methyl group at the 17-alpha position and a carboxylic acid group at the 17-beta position

Mechanism of action

Binds to androgen receptors, promoting the development of male characteristics and increasing protein synthesis in muscle cells

Half-life

Not specified in the material provided

Dosage

Not specified in the material provided

Route of administration

Not specified in the material provided

Duration of action

Not specified in the material provided

Onset of action

Not specified in the material provided

Elimination

Not specified in the material provided

Drug interactions

Not specified in the material provided

Upstream product

• 53-06-5 Cortisone 
• 64-17-5 ethanol 
• 7664-93-9 sulfuric acid 
• 95283-08-2 20-Hydroxy-3,11-dioxo-pregn-4,17⁽²⁰⁾-dien-21-al 

Downstream Products

• 128802-63-1 Cortisone 21-(S)-α-Methoxy-α-(trifluoromethyl)phenylacetate 
• 128802-59-5 17α-Hydroxy-17β-<<(S)-α-methoxy-α-(trifluoromethyl)phenylacetoxy>methyl>androst-4-ene-3,11-dione 
• 53-06-5 Cortisone 
• 382-45-6 adrenosterone 

Relevant articles and documents

-

-

Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids

Methods for treating angiogenesis, tumors, and ocular hypertension with steroids are disclosed herein. The steroids have angiostatic activity with reduced glucocorticoid activity.